B |
2020-09-24 16:47:28.0 |
CymaBay Therapeutics |
CBAY |
Avoro Capital Advisors LLC |
14.95% |
view |
S |
2020-02-14 10:21:44.0 |
CymaBay Therapeutics |
CBAY |
Foresite Capital Fund III |
5.6% |
view |
S |
2020-02-05 11:45:56.0 |
CymaBay Therapeutics |
CBAY |
INTEGRATED CORE STRATEGIES |
4.4% |
view |
S |
2019-02-13 16:29:16.0 |
CymaBay Therapeutics |
CBAY |
ADAGE CAPITAL PARTNERS GP |
3.63% |
view |
B |
2018-02-13 15:45:16.0 |
CymaBay Therapeutics |
CBAY |
Foresite Capital Fund III |
6.5% |
view |
B |
2017-11-14 16:02:19.0 |
CymaBay Therapeutics |
CBAY |
Foresite Capital Fund III |
6.2% |
view |
S |
2017-02-14 20:37:49.0 |
CymaBay Therapeutics |
CBAY |
ADAGE CAPITAL PARTNERS GP |
6.43% |
view |
B |
2016-02-16 11:30:01.0 |
CymaBay Therapeutics |
CBAY |
ADAGE CAPITAL PARTNERS GP LLC |
7.25% |
view |
B |
2015-02-17 06:14:11.0 |
CymaBay Therapeutics |
n/a |
Versant Affiliates Fund II |
6.8% |
view |
B |
2015-02-11 11:02:54.0 |
CymaBay Therapeutics |
n/a |
Lombard Odier Asset Management |
9.32% |
view |
B |
2014-02-14 15:52:49.0 |
CymaBay Therapeutics |
n/a |
Versant Affiliates Fund II |
11.9% |
view |